Virchow Biotech Private Limited

THE VIRCHOW GROUP with an operational experience of over 4 decades has a global footprint in over 100 countries supporting about 3,500 employees with an annual turnover of over $600 million. The Virchow Group has a diversified business portfolio ranging from Biogenerics, Pharmaceuticals, Medical devices, and APIs. The group is the largest producer of Sulfamethoxazole and Ranitidine Hydrochloride in the world.

VBPL is an ISO 13485:2012 and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. We also have offices located in USA. Innovative, ever motivated Research team and uncompromising manufacturing team in providing quality products are our strengths.

We are globally known as “the first company to commercialise Biogenerics of Recombinant Platelet Derived Growth Factor (rhPDGF) for wound healing, Recombinant PTH of treating Osteoporosis ”. Pegylated Interferon and Rasburicase are other products in this sector.

Apart from this we also offer Contract Research and Manufacturing services, codevelopment of products for various markets and customers around the world. Our quality standards and dedicated team gifted us with ever appreciating International and Domestic customer base. Our cGMP practices in facilities accredited by various regulatory agencies.

VBPL is an ISO 13485:2012 , USFDA and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. Our focus regions are South-East Asia, Russia-CIS, Africa, LATAM, and South-Asia. We are having a good client base across the globe and aiming for swift expansion in next 2 years.